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ABSTRACT OF THE DISSERTATION

Mechanosensitive Epithelial Cell Scattering and Migration on Layered Matrices
by
Christopher Walter
Doctor of Philosophy in Biomedical Engineering
Washington University in St. Louis, 2019
Professor Amit Pathak, Chair

Epithelial cells form multi-layered tissue scaffolding that makes up every organ in the body.
Along with epithelial cells, the basement membrane (BM) and connective tissue are composed of
various proteins that sculpt the organs and protect them from foreign macromolecules. Epithelial
cells respond to various cues, both chemical and mechanical, from their surrounding matrices to
aid in maintenance and repair of these layers through degradation and deposition of extracellular
matrix (ECM) proteins. In cancer progression, epithelial cells lose their normal function of
supporting tissue structure and instead adopt more aggressive behaviors through an epithelial-tomesenchymal transition (EMT) of their cellular traits. In some cases, these cells may break away
from the primary tumor and begin to develop a secondary tumor elsewhere, a process known as
metastasis. In these processes, cells are constantly interacting with highly heterogeneous and
layered matrices that can influence cell behavior. This dissertation investigates how mechanical
properties of both intact and defective layered matrices influence epithelial cell response.
Chapter 1 details an introduction to epithelium structure and health, as well as how the
mechanical properties of the matrix supporting the epithelium structure regulate epithelial cell

ix

behavior. Chapter 2 investigates the role of basement membrane (BM) integrity in maintaining
epithelial monolayer health. A common outcome of EMT is degradation of surrounding ECM as
cells become more mechanically active and migratory. Conversely, it is not known whether a
break or defect in the BM could, in turn, induce EMT. We address this question in two parts.
First, we layer BM-mimicking collagen-IV coatings onto tunable polyacrylamide (PA)
hydrogels, induce a defect into the layered hydrogel, and then culture normal epithelial cell
networks on the defect-laden substrates. Second, we layer the BM-like matrix atop a collagen
matrix to investigate the impact of the BM defect on cell invasion. Our results show that defects
in BM-mimicking substrates induce EMT in normal epithelial cells by promoting degradation of
the BM itself, triggering mechanical activation of normal epithelial cells in 2D and further
progressing EMT induction. We also demonstrate that BM defects can trigger epithelial cell
invasion into the surrounding ECM through the same BM degradation mechanism. In chapter 3,
we address the ability of normal and cancerous epithelial cells to sense distant matrix stiffness.
Epithelial cells have been shown to be highly sensitive to substrate stiffness, particularly the
stiffness of their immediate surroundings. However, epithelial cells reside in layered
environments in which distinct layers stiffness and fiber structure can vary greatly. Yet, little is
known about the ability for epithelial cells to sense these distant layers. Here, we investigate the
extent to which distant matrix stiffness can affect cell migration by fabricating collagen-I
matrices of varying thickness onto PA hydrogels of tunable stiffness. We have found that while
normal epithelial cells are only able to sense the stiffness of their immediate surroundings,
cancer cells show sensitivity to distant matrix stiffness through fibrous collagen matrices.
Cancerous epithelial cells are able to sense distant matrix stiffness through greater actin fiber
assembly, cell force generation, and by utilizing the fibrous intermediate collagen matrix to

x

deform the distant PA substrate. By inhibiting the force-generating cellular machinery or by
crosslinking the collagen network, we eliminate the ability of cancer cells to sense distant matrix
stiffness. Our findings show that cancer cells may be affected by more than just their immediate
surroundings, and, in turn, may influence the behavior of distant epithelial cells.
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Chapter 1: Introduction: Epithelial Health
and Response to Layered Matrices
1.1 Epithelium
Organ structures throughout the body are comprised of a variety of proteins and cells,
naturally arranged into layers. Starting with the outermost, the first layer consists of a sheet of
epithelial cells. The shape of these can vary, however they generally form thin, tightly connected
sheets that are important for maintaining organ health as a first layer of defense from external
chemical signals and damage.1,2 Epithelial cell sheets are held together through cell-cell contacts
formed by gap, tight, and adherens junctions.1 Cadherins, specifically E-cadherin, construct
physical connection between the cells and thus enable communication of forces throughout the
monolayer of cells.1,3 This physical cell-cell communication is important for regulating the
overall health of the epithelium. The cell-cell junctions are balanced by cell-matrix adhesions to
the underlying thin sheet of matrix known as the basement membrane.4
The basement membrane is a thin sheet of various proteins, including multiple structural
proteins, like collagens and fibrillin, and various anchoring proteins such as integrins and
laminins.5 Specifically, collagen type IV makes up the majority of the structural component to
the basement membrane. Collagen-IV forms a thin (~50 nm thick) densely connected network
within which the various anchoring proteins are “hooked.”5 This tight network of matrix proteins
helps to maintain the health of the epithelial cells that reside on it, thereby also protecting the
interior of the organ from inward transport of harmful elements, such as viruses and chemical
factors.6-8
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Attached to the basement membrane lies the connective tissue.9-11 Whereas there are some
specialty types of connective tissue, in general, the connective tissue is comprised of a structural
interstitial matrix and sparse quantities of fibroblasts.2 The interstitial matrix is composed of a
fibrous network of collagens, mainly collagen type I, and elastin, a component that gives the
tissue and organ its elasticity.12 Individual collagen fibers form triple-helical fibrils, which then
link with other fibrils to create an interconnected fibrous network of matrix.13 The fibroblasts
that reside within the matrix are responsible for maintaining this network through protein
degradation, excretion, and network remodeling.14,15 As mentioned previously, the connective
tissue, as well as the other components of this layered nest are critically important to maintaining
organ health and function and preventing serious diseases.

1.2 Epithelial Cell Sensing and Response
As mentioned previously, epithelial cells are anchored to the basement membrane through
cell-matrix adhesions.5 Through these adhesions, cells are able to deform the surrounding matrix
and thus “sense” its various properties, both chemical and mechanical.16-20 To sense their
surrounding matrix, random polymerization of intracellular actin globules cause the cell
membrane to bleb out and allow for connection of transmembrane proteins to anchoring matrix
proteins. As internal polymerization of actin continues, cells begin to develop a front-rear
polarity, which can be stochastic, or guided by external properties, such as matrix fibers or
stiffness. As this planar cell polarity continues to develop, the actin cytoskeleton becomes
reinforced, allowing for cells to generate greater forces, in turn able to greater sense their
surrounding matrix. As cells sense matrix stiffness and topography, the internal protein
production is simultaneously modified to alter cell behavior to appropriately accommodate its
environment.
2

1.3 Epithelial Health
As extracellular properties change through varying stages of development or disease, broad
changes in epithelial behavior can occur through the mechano-sensing ability of individual cells.
Some of the important biological processes in which normal function of epithelial cells play
critical roles include development, wound healing, and immune response.21-28 Such malfunctions
can also lead to dysfunction in epithelial layers, which can lead to many pathological
abnormalities, including cancer and fibrosis.29-35
Epithelial cancers are some of the most aggressive due to their tendency to metastasize.36-38
Metastasis is the process of cancer cells breaking away from the primary tumor, entering the
blood stream, and then exiting the blood stream in a second location, beginning the development
of a new tumor.37,38 Although the circulatory system gives access to the entire body, some more
common sites of secondary metastases include the lungs, bones, and liver.39 As epithelial cells
break away from the primary tumor site, they begin to adopt more aggressive phenotypes,
suitable for degrading their surrounding matrix and migrating to surrounding blood vessels.37
This process is known as the epithelial to mesenchymal transition (EMT). The unpredictability of
epithelial malfunction and the resulting tumor invasion makes cancer difficult to treat.

1.4 Epithelial to Mesenchymal Transition
The EMT is a process through which epithelial cells lose their native, quiescent state and
begin to express more aggressive phenotypes. Typically, this process is identified by changes in
cell morphology, migration, and broad changes in their gene expression profile.19,20,29,31,37,40-42 As
cells begin to break away from their epithelial sheets, they become more polarized and develop a
strong, coordinated actin cytoskeleton.37 This cytoskeleton then becomes reinforced with
vimentin, an intermediate filament, and microtubule assemblies.38,43 This reinforced cytoskeleton
3

allows cells to generate greater forces, allowing for manipulation and restructuring of their
surrounding ECM and faster migration.38,43 Within the nucleus, various transcription factors
become highly upregulated, promoting or modifying these listed behaviors as well as a litany of
others, including proliferation, cell cycle maintenance, programmed cell death, and external
signaling pathways.19,29,37,38,44 It is through this process that epithelial cancers become
unpredictable and both difficult to treat, as well as dangerous to health.
There are a number of environmental factors that can stimulate this behavior, such as
chemical signaling16-18, like that of signals from a neighboring tumor, and mechanical properties,
such as stiffness, porosity, and geometry.19,20 Understanding the effects of these properties on
epithelium health and behavior are critical to the development of adequate, appropriate
therapeutic strategies for treating aggressive epithelial cancers.

1.5 The Importance and Process of Cell Migration
An important aspect of tissue and organ development, wound healing, and cancer metastasis
is cell migration. During tissue and organ development, cells must migrate to aid in forming the
tissues themselves, while during wound healing, cell migration aids in closing the physical
wound.45,46 In cancer, a well-known dangerous aspect of tumor cells is the ability for cells to
metastasize and migrate away from the primary tumor site to form secondary tumors elsewhere.
Cell migration is a multi-step process that involves the coordination of both intracellular and
extracellular components. As described previously,47 cells first probe their immediate ECM and
create focal adhesions with local ECM proteins. Due to the distribution of ligands and small
differences in the microenvironment, the distribution of cell adhesions will tend to accumulate in
one general direction.47 As cells continue to create focal adhesions, actin filaments polymerize
within the cell, aligning the cell in the direction of the focal adhesions, causing it to become
4

polarized.48,49 As actin polymerization increases, actomyosin contractility forces increase along
the actin fibers. Whether it be by ligand density or differences in local ECM stiffness, the force
generated by the cell tends toward one direction. Once the force generated by the cell is greater
than the opposing adhesive forces, the cell migrates in the direction of the leading edge. Due to
the nature of this phenomenon, modifying and patterning the ECM in numerous ways, both
chemical and mechanical, can control cell migration.

1.6 Significance of Understanding Epithelial Cell Behavior
in Layered Matrices
Previous studies have indicated that matrix stiffness is a potent regulator of a variety of cell
behaviors in a variety of cell types. Mesenchymal stem cells have been shown to differentiate
into neuronal cells on soft substrates, while on stiff substrates they differentiate into
osteoblasts.22 Fibroblasts and smooth muscle cells are also sensitive to substrate stiffness,
showing increases to cell area and polarity, reduction in cell roundness, and faster migration on
stiff substrates.23,50-53 Much like these other cell types, epithelial cells have been shown to exhibit
sensitivity to a variety of substrate properties, including changes to cell morphology, migration,
and the process of EMT.19,54,55
As the matrix stiffness increases, so does the propensity for epithelial cells to undergo EMT,
as seen by their increase in cell area, polarization, and migration speed.19,54,55 These behaviors
occur as a result of upregulation of pro-EMT genes, or genes that promote more aggressive,
mesenchymal behaviors, such as SNAI1 and Zeb1.29,56,57 When grown on substrates of varying
stiffness, epithelial cells show a tendency to gravitate towards the stiffer substrate, both as single
cells and whole cell collectives.23,58 These behavioral changes all contribute to an overarching
behavior similar to that of cancerous epithelial cells.
5

These previous studies have laid the groundwork of how epithelial behavior responds to
changes in the stiffness of their immediate environment. However, as I previously stated, the
native ECM is a highly layered matrix, comprised of a variety of proteins and cells, each having
their own contribution to the equilibrium of epithelial structures. It is possible that distant matrix
properties could affect epithelial cell behavior much like the immediate matrix properties. How
cells are able to distinguish these layers is still relatively unknown. Previous work has begun to
investigate the ability for cells to sense distant stiffness, but the results and studies themselves
have been limited. For smooth muscle cells, cardiomyocytes, and epithelial cells, it has been
shown that as substrate (soft polyacrylamide) thickness was increased, the distance from the
underlying stiff glass increased and cell spreading decreased, similar to cells on soft substrates.5962

In this ‘deep sensing’ of distant matrix stiffness, the ability of cells to form robust adhesions

and generate forces is found to be a critical component.60
A limitation to these studies is the choice of substrates used to represent the layers in the
native ECM. The collagen structure found within the connective tissue is highly fibrous and
viscoelastic, directly contrasting the linear elastic polyacrylamide matrix.63-66 In order to better
understand how layered matrices and distant matrix properties affect epithelial cell behavior,
more accurate experimental platforms must be created to represent the in vivo nature in which
epithelial cells reside. Understanding the effect of both distant and immediate ECM properties on
cell behavior is key to developing a greater understanding of many biological processes, as well
as developing adequate treatment therapies for pathologies arising from epithelial dysfunction.
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Chapter 2: Physical defects in basement
membrane-like collagen-IV matrices trigger
mesenchymal transition in normal epithelial
cells
2.1 Introduction
In pathogenesis of cancer and fibrosis, the epithelial integrity is compromised through an
epithelial-mesenchymal transition (EMT) of cells.67 Additionally, the basement membrane (BM)
matrix is degraded as the disease conditions progress.9 As a result of these cellular and
extracellular malfunctions, the cells transformed by the EMT invade through the BM and into the
surrounding stroma.68 Despite the known importance of the integrity of epithelial junctions and
BM composition in healthy tissues, a connection between their dysfunctional transformations
remains unclear.
The BM matrix is a thin and dense sheet-like network of extracellular matrix (ECM)
proteins, which is connected to the basolateral side of epithelial or endothelial cells throughout
mammalian organs and tissues.69 This membrane is essential for maintaining the health of the
underlying tissue by providing structural support at the epithelium-stromal interface and serving
as a barrier to foreign macromolecules.6 Healthy BM structure plays an important role in
preventing the invasion of cancer cells into the vasculature.7 In breast cancer metastasis,
basement membrane degradation is one of the key steps in the transformation of an in situ tumor
into an invasive one.70 Collagen type IV (col-IV) is the majority constituent in the BM
composition, along with laminins, heparan sulfate proteoglycans, and nidogens.7,8 The col-IV
fibrils in the BM form a highly cross-linked network with occluded binding sites for other
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proteins.71,72. This networked col-IV prevents BM degradation and invasion of attached epithelial
cells into the stromal matrix.7,9-11 However, as epithelial cells undergo EMT, they start to break
cell-cell junctions, become fibroblastic, and attain motile characteristics, enabling them to
deform and degrade their underlying BM; all of which are crucial early events in tumor
invasion.67 It is now known that matrix stiffness triggers EMT in epithelial cells through cellular
mechanoactivation.73-75 Furthermore, matrix topography, confinement and spatial patterning of
ligands can induce EMT-like signatures in epithelial cell populations.19,76,77 These matrixdependent mechanosensitive modes of EMT are particularly relevant for fibrosis78 and cancer,75
where mechanical properties of the tissue microenvironment undergo dramatic changes during
disease progression. Thus, it is possible that physical heterogeneities in the BM could break the
symmetry in normal epithelial layers and trigger similar ECM-dependent pathogenic cellular
transformations.
The EMT and associated stimulation of matrix metalloproteinases (MMPs) and cellular
mechanoactivation have been shown to degrade the BM matrix in wound healing,30
development,42,79 and cancer progression.80,81 Aside from pathological reasons and cellular
transformations, the BM matrix can also sustain damage due to physical wounds, incisions, or
surgeries. Although a homogeneous soft BM matrix is known to protect the epithelial state, it
remains unknown whether mechanical heterogeneities and defects in the BM contribute to
pathologically-relevant cellular transformations. In this study, we ask this converse question –
can preexisting physical defects in healthy and soft BM-like matrix cause EMT and invasion in
normal epithelial cells? If true, this finding will reveal that the heterogeneous transformation of
the BM structure during disease progression is not merely a passive outcome but an active
instigator of cellular EMT.
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To address this question, we fabricated a soft polyacrylamide (PA) gel, one that protects
against EMT, functionalized a layer of col-IV to mimic BM-like properties, and manually
introduced a tear in the gel. Given that col-IV represents the majority structural component of the
BM matrix and that physical properties of the BM are the focus of our study, we chose it as the
primary ECM protein for our in vitro BM-mimicking scaffolds. We cultured MCF10A human
mammary epithelial cells and found enhanced EMT markers around this physical matrix defect.
We also measured how two different anomalies in the BM-like matrices – physical defects in
soft matrix or homogeneous stiff matrix – cause EMT and cellular mechanoactivation. Through a
new computational model that integrates cellular forces, cell-cell junctions, mechanoactivation
and EMT in a multi-cell network, we simulated the spatiotemporal evolution of EMT
progression and cellular mechanoactivation around the defect. Through a novel 3D scaffold
combining both BM-like and stroma-like matrices, we showed that the defect-induced EMT not
only persists in 3D, but also causes downward cell invasion. These findings demonstrate that the
known degradation of BM caused by cellular EMT and invasion68 might not be a one-way
process. Instead, our results reveal a previously unidentified ability of normal epithelial cells to
exploit the physical defects in the BM matrix to attain EMT and invasive phenotypes.

2.2 Materials and Methods
2.2.1 Fabrication of collagen IV-coated PA gels with defect
Glass coverslips were activated by plasma cleaning and Bind-Silane solution (94.7%
ethanol, 5% acetic acid, and 0.3% Bind-Silane). After 10 minutes, the coverslips were washed in
ethanol and air dried. Polyacrylamide gels were synthesized by free-radical polymerization
according to protocols previously established.55,63,82 Precursor solutions combining acrylamide,
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bis-acrylamide, and ultrapure water were mixed at a ratio of 10%, 0.15%, and 89.85%
respectively for ~50 kPa and 4%, 0.2%, 95.8% for ~0.5 kPa stiffness, as characterized before82
and confirmed here (Fig. 2.1). A solution of 10% ammonium persulfate was added along with
N,N,N’,N’-tetramethylethylene diamine (TEMED) at 1:200 and 1:2000 v:v, respectively.
Polyacrylamide solution was applied to the activated coverslips using a Sigmacote
(MilliporeSigma, St. Louis, MO) treated microscope slide and allowed to polymerize for 30
minutes. Formed gels were functionalized with 0.5 mg/mL solution of sulfosuccinimidyl 6-(4'azido-2'-nitrophenylamino) hexanoate (Sulfo-SANPAH) (Thermo Fisher Scientific) prepared in
50mM HEPES buffer (Santa Cruz Biotechnologies) and crosslinked to the PA surface upon
activation with 365 nm UV for 10 minutes. Gels were then washed 3 times before applying a 0.5
mg/mL solution of type-IV collagen from human placenta (col-IV) (Millipore Sigma, St. Louis,
MO). After col-IV application, coverslips were placed at 4oC overnight (<12 hours), then
washed. A scalpel was used to make an incision 1 cm in length immediately prior to cell
addition. Cells were plated onto gels within 24 hours of col-IV deposition.

2.2.2 Cell culture
MCF-10A cells were cultured in DMEM/F12 supplemented with 5% horse serum, 0.2%
Normocin, 20 ng/mL EGF, 0.5 mg/mL hydrocortisone, 100 ng/mL cholera toxin, and 10 µg/mL
insulin, as previously established.82-84 Media was changed every 3 days. For MMP9 inhibition
experiments, cells were treated with the MMP9 Inhibitor (CAS 1177749-58-4; Calbiochem) at 5
nM concentration.

2.2.3 Immunofluorescence and image analysis
After 1, 3, or 6 days of culture, the cells were fixed with 4% Paraformaldehyde for 10
minutes, washed, and permeabilized using 0.1% solution of Triton X-100 for 15 minutes. Cells
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were washed again and non-specific binding was blocked by 3% Bovine Serum Albumin (BSA)
solution in PBS containing 0.1% Tween-20 for one hour. Primary antibody solutions were
incubated overnight at 4oC. Secondary antibody solutions were incubated for one hour at room
temperature. Primary antibodies used were against col-IV (1:500; Abcam,), MMP9 (1:500;
Invitrogen), E-Cadherin (1:200; Cell Signaling), pMLC (1:500; Invitrogen) and Vimentin (1:750;
Pierce Biotech). Secondary antibodies used were goat anti-rabbit Alexa 647 (1:300; Life
Technologies) and goat anti-mouse Alexa 488 (1:300; Life Technologies). F-actin was stained
using rhodamine phalloidin (1:400; Life Technologies). Once stained, coverslips were mounted
in Slowfade Diamond with DAPI (1:250; Life Technologies) onto microscope slides and sealed
with a number 1.5 coverslip. Images were taken using an Olympus FV1200 scanning laser
confocal microscope using an UAPON 40XW340 objective. Unless otherwise specified, all
experiments were carried out with 3 experimental replicates and at least 6 technical replicates.
Image analysis was performed using FIJI. E-cadherin membrane localization was calculated by
dividing the E-cad expression on the cell membrane by the total E-cad expression to obtain a
normalized ratio for each cell. Quantification of vimentin, pMLC, and col-IV was performed by
measuring the pixel intensity per unit area in images with a cell monolayer present and only in
areas in which cells were present (areas beyond the defect were not considered in the
calculations). To quantify actin fiber formation, the average background intensity across all
conditions was calculated and subtracted from each image, leaving behind only the high intensity
actin stress fibers. Pixel intensity was then calculated from these images. To account for
discrepancies in cell number and monolayer area, only data from full, unbroken areas of the
monolayer were considered and all data were normalized by the area measured. Long-distance
vimentin images were obtained by imaging gel constructs with complete monolayers that
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extended >3 mm from the induced defect. Images were acquired in tiles using a laser-scanning
confocal microscope (Ziess LSM 810; Carl Ziess MicroImaging; Germany) using a 40X
objective and stitched together using ZEN2.1 software.

2.2.4 Fabrication of multi-layered 3D matrices and invasion analysis
To measure 3D cell invasion around the defect, a 3D ECM was fabricated by layering a
coating of BM-mimicking col-IV on top of a matrix of stroma-mimicking Rat Tail Type I
collagen (col-I; Santa Cruz Biotechnology). First, polyacrylamide gels were synthesized on
coverslips and treated with Sulfo-SANPAH as with the aforementioned 2D substrates, after
which 50 μL of col-I at a concentration of 0.5 mg/mL was applied and allowed to polymerize for
1 hour at 37oC. After the col-I layer had polymerized, a 0.5 mg/mL concentration col-IV solution
was applied and allowed to polymerize overnight at 4oC. A crack was introduced after at least 12
h incubation. Cells were then seeded as a monolayer on the PA/col-I/col-IV layered scaffold and
the cells were allowed to grow for 6 days. For immunofluorescence imaging, a similar procedure
compared to the procedure used for the 2D gels was used here. A primary antibody against type-I
collagen (Abcam) was used for staining the col-I matrix. Images were obtained using the Zeiss
LSM 810 confocal microscope with 2 µm thick z-stacks. Invasion cell counts were obtained by
counting the number of whole nuclei present within the 2 µm stack. Cell counts were also
divided into 100 µm sections measured from the defect.

2.2.5 qPCR
Cells were grown on gels that contained 5 defects, spaced 3 mm apart, in order to
maximize the number of cells exposed to the network break. These multiple cut gels were used
for extracting mRNA for qPCR analyses. mRNA was extracted using Qiagen Quick RNA
extraction kit (Qiagen) according to manufacturer’s instruction. Primers for SNAI1, Zeb1,
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PTEN, and RRNA18 (Qiagen) were used and experiments were performed using SYBR green
(Qiagen). Results were normalized and evaluated by geometric mean outlined by Livak &
Schmittgen.85

2.2.6 AFM
Atomic Force Microscopy (AFM) measurements of polyacrylamide gels were made
using an MFP-3D-BIO atomic force microscope (Asylum Research, Santa Barbara, CA).
Olympus TR400PB AFM probes with an Au/Cr coated silicon nitride cantilever and pyramidal
tip were used, with spring constants ranging from 20-30 pN/nm as measured by thermal
calibration (Asylum Research, Santa Barbara, CA). 50 μm x 50 μm force maps were taken at the
location of the defect (<200 m), away from the defect (>2 mm), and on control substrates, with
100 points per force map. Elastic moduli were extracted from force curves using a modified
Hertz model, as described earlier.86

2.2.7 Statistical Analysis
Unless specified otherwise, results are reported as the mean + Standard Error (SE). To
identify the significant differences between two experimental conditions, an F-test was
performed to determine whether equal variance could be assumed. Next, Student’s t-test was
used to determine significant differences between two groups. All statistical analyses were
performed using the Data Analysis toolbox in Microsoft Excel. Differences were considered to
be significant for P<0.05.

2.3 Physical defects in collagen-IV basement membrane
induce EMT in 2D epithelium
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2.3.1 Fabrication of layered BM-mimicking hydrogel substrates.
To culture cells on a BM-like substrate, we fabricated PA hydrogel substrates of defined
stiffness, prescribed through ratios of monomer and crosslinker,19,55,63 and of at least 100m
thickness on a glass coverslip (Fig. 2.1A). We picked a low PA stiffness of ~0.5 kPa, because it
preserves the epithelial state of the cell monolayer in control matrix settings (homogeneous gel
without defects). It is important to perform measurements of defect-induced EMT on soft
substrates, because stiff ECMs are known to induced EMT through activation of the TGF-
signaling pathway, regardless of matrix topography or structure.19,73,75,76,78 Next, we
functionalized the PA gel surface and coated a layer of 0.5 mg/ml col-IV, which is a majority
ECM protein in the BM matrix. Afterwards, we introduced a tear in the soft PA gel as described
in Methods, resulting in an average defect width of ~40m width (Figs. 2.1A,B,D).
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Figure 2.1. EMT induction around physical defects in soft BM-like col-IV matrix. (A) In
four steps, soft PA gel is fabricated, col-IV layer is deposited, a defect is introduced in the
form of a tear, and MCF10A cells are seeded. (B) Orthogonal projections of a representative
immunofluorescent image with x- and y- profiles (blue and white lines, respectively) of the
imposed defect in col-IV coated PA gels using col-IV antibody (Abcam) with Alexa Fluor
488 ELISA and 0.5 m diameter fluorescent beads, respectively. This allowed for both defect
width and depth measurements, averaging 54 and 65 m, respectively. (C) Average Young’s
Modulus measured by AFM of soft PA gels prior to the introduction of defect (no defect),
near the defect, and away from defect, as well as homogeneous stiff PA gels. (D) Average
defect width measured via immunofluorescent images, as shown in (B). Box represents 25-75
percent of data. Whiskers represent outliers. Error bars = SEM. (E) Average defect depth
measured via immunofluorescent images, as shown in (B). Box represents 25-75 percent of
data. Whiskers represent outliers. Error bars = SEM.

Through Atomic Force Microscopy (AFM), as done previously,55,86 we verified that the
introduced physical defect in the PA gel does not cause significant change to its stiffness (Fig.
2.1C). Since only the top surface of the PA is functionalized and coated with protein, the inner
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surfaces of the defect remain uncoated, prohibiting any attachment to the inside walls of the
defect. By comparing col-IV images before and after introducing the defect (Fig. 2.2), we
verified that cutting the gel does not create an aligned pattern of col-IV along the defect, which
could have introduced an additional topographic cue. In rare cases, if some col-IV lands within

Figure 2.2. Creating defect does not result in loss of col-IV prior to cell seeding.
Representative immunofluorescence images of col-IV before (left) and after (right) creating
the defect. Scale bar=100m.
the valley of the defect, any cells within the defect (near the bottom surface) are unable to
interact with the cell monolayer cultured on top of the PA gel (Fig. 2.3).
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Figure 2.3. Cells that manage to seed at the bottom of the interior of the defect are
unable to interact with cell monolayer. Representative immunofluorescence image of cell
clusters at the bottom of the interior of the defect (white arrows) compared to the cell
monolayer. Cells are stained for Actin (red) and DAPI (blue). Scale bar=50m.

2.3.2 Preexisting defect in collagen IV-coated soft matrix induces EMT in
epithelial monolayer
On soft col-IV-coated PA gels, both with and without defect, we cultured MCF10A cell
monolayers for 3 days. After fixing the samples, we stained and imaged for E-cadherin (an
epithelial marker) and vimentin (a mesenchymal marker). For control measurements, we
repeated experiments on homogeneous, i.e., without a defect, PA gels of the same stiffness. We
observed a nearly 4-fold increase in vimentin expression due to the presence of the defect (Figs.
2.4A,B), a reduction in E-cad membrane localization by ~35% (Figs. 2.4A,C), and a rise in cell
spreading and elongation (Figs. 2.4D,E), all of which are signatures of EMT. We also imaged for
col-IV near the gel surface in each condition and found that the level of col-IV around the defect
decreased by ~50% compared to the homogeneous substrates, which indicates col-IV
degradation occurring concurrently with EMT induction (Figs. 2.4F, 2.5).
17

Figure 2.4. EMT induction around physical defects in soft BM-like col-IV matrix. (A)
Representative immunofluorescence images of E-cad (green), vimentin (red), and DAPI
(blue) in MCF10A monolayers on soft (0.5 kPA) PA gels with and without (homogeneous
controls) defect. Scale bar=50m. (B) Average vimentin expression, (C) membrane
localization of E-cad, (D) spreading area of individual cells within the monolayer, (E) cell
aspect ratio, and (F) average col-IV expression. N>30. (G) qPCR measurements of SNAIL,
ZEB1, RhoA, and PTEN levels relative to GAPDH controls, plotted as fold change (ct)
compared to the levels on soft control matrices. Error bars = SEM. *p<0.01, and **p<0.001
compared to soft substrates.

To confirm EMT through molecular analyses, we extracted mRNA from MCF10A cells
on gels with and without defects and performed qPCR. We chose primers for SNAIL, ZEB1,
PTEN, and RhoA as a marker for cell mechanoactivation. We found that the levels of SNAIL
(SNAI1) and ZEB1, both of which are hallmark transcriptional factors for EMT, increased over
two-fold (Fig. 2.4G). We also found that PTEN level, which dephosphorylates PI3K87,88 to
maintain epithelial phenotype, was reduced by ~50%. Surprisingly, the RhoA activation
remained undetectable and similar to the control soft gels, even as the EMT markers were
enhanced after 3 days of culture on defective gels. These findings show that physical defects in
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col-IV-coated soft matrices can induce EMT in normal epithelial cells within 3 days of culture
without a prior RhoA-based cellular mechanoactivation.

Figure 2.5. Presence of mechanical defect stimulates degradation of the underlying colIV. Representative immunofluorescence images of col-IV and DAPI on soft control and softdefect PA gels after 3 days of monolayer culture, corresponding to the data presented in Fig.
2.4F. Dashed line is used to emphasize edge of defect. Scale bar=50m.

2.3.3 Stress fiber formation on soft col-IV matrices rises after defect-induced
EMT, but stiff matrices induce EMT and stress fibers more rapidly and
concurrently.
To measure the chronological sequence of EMT and stress fiber formation, a signature of
cellular mechanoactivation, we compared the expressions of aligned F-actin fibers,
phosphorylated myosin light chain (pMLC), and vimentin after 1, 3, and 6 days of cell culture on
the defective soft matrix (Fig. 2.6). Cells cultured for only 1 day on soft or defective soft
matrices showed low vimentin expression (Fig. 2.6). After 3 days, however, vimentin expression
on defective soft matrices increased by over 3-fold compared to day1 and by nearly 4-fold
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compared to the homogeneous soft matrices, continuing to increase by another ~50% over 6 days
(Fig. 2.6B). In contrast, for the soft-defect case, the expression of actin fibers remained low in
the first 3 days and then rose by more than 5-fold over 6 days (Fig. 2.6A,C). Since stress fiber
activity combines both actin and myosin expressions, we also measured pMLC expression (Figs.

Figure 2.6. Defect-induced EMT precedes stress fiber formation, but stiffness-induced
EMT and stress fibers evolve concurrently. (A) Representative immunofluorescence
images of F-actin (red) and DAPI (blue) in MCF10A monolayers on soft, soft-defect, and
stiff PA gels after 1, 3, or 6 days in culture. Scale bar=50m. Average expressions of (B)
vimentin, (C) actin fibers, and (D) pMLC across the three ECM conditions after 1, 3, and 6
days. N>20. Error bars = SEM. *,# p<0.01 compared to soft control ECM. Horizontal lines
above bars indicate p<0.01 between the indicated substrate conditions.
2.6D,), which followed trends similar to the actin fiber formation and vimentin expression.
Since the matrix-dependent EMT has conventionally been associated with matrix
stiffening,19,75,78 we compared EMT and stress fibers on col-IV-coated homogeneous (without
defect) stiff matrices of ~50 kPa Young’s Modulus (Fig. 2.1C). We found that vimentin
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expression, pMLC, and actin fibers increased by the first day in culture and stayed high over 6
days of culture (Figs. 2.6A-D). These results indicate that soft col-IV matrix requires a defect to
induce EMT, but sufficiently stiff matrix does not. To test whether slight stiffening of the matrix
can trigger EMT in the absence of defect, we repeated these measurements after 3 days of culture
on a col-IV coated PA gel of ~1.3 kPa stiffness, which is over three-times the stiffness of the
control soft matrix, and found that vimentin expression and stress fiber formation remained at the

Figure 2.7. BM defect is necessary to induce EMT in MCF10a cells even on ~3x stiffer
substrate. (A) Representative immunofluorescence images of actin, vimentin, pMLC, and
DAPI in cells on BM substrates ~3x stiffer (1.3 kPa) than soft (0.5 kPa) substrates. Scale
bar=50m. (B) Average Young’s Modulus measured by AFM of 5% acrylamide, 0.2% bisacrylamide PA. Average expressions of (C) actin fibers, (D) vimentin, and (E) pMLC across
the four ECM conditions after 3 days. N>20. Error bars = SEM. Horizontal lines above bars
indicate p<0.01 between indicated substrate conditions.
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low levels observed for the control soft matrix (Fig. 2.7).
These temporal results highlight that the defective soft col-IV matrix first induces EMT
within the first 3 days, which is followed by broad cellular mechanoactivation and further surge
of EMT over 6 days. In contrast, on the stiff matrix, cellular mechanoactivation and EMT occur
both rapidly and somewhat concurrently, with increased stress fiber formation and EMT markers
within 1 day, followed by a continued rise over 6 days.

2.3.4 Inhibition of MMP9 disables col-IV degradation and defect-induced
EMT.
Since EMT signatures rose without significant cellular mechanoactivation (stress fibers
and RhoA activity) within 3 days for the soft-defect case, we sought to investigate other factors
associated with the defective col-IV matrix. Earlier, we found a reduction in col-IV expression
on the defective matrix compared to the homogeneous substrates (Figs. 2.4F, 2.5), which
indicated cellular degradation of col-IV, enabled by the mechanically introduced defect. Given
that MMP9 is known to play a crucial role in degradation of col-IV,89 we repeated our
measurements after treating the cells with a pharmacological inhibitor of MMP9. The efficacy of
the inhibitor was confirmed using an MMP9 inhibitor assay kit (Abcam), as shown in Fig. 2.8.
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Figure 2.8. Validation of efficacy of used MMP9 inhibitor. Amount of MMP9 activity
over time (left) and total activity (right) on samples with no inhibitor (black), supplied
verification inhibitor (red) and experimental inhibitor used in this study (blue).
As expected, treatment with MMP9 inhibitor resulted in a loss of col-IV degradation on
defective soft matrices (Figs. 2.9B, 2.10). The MMP9-inhibited cells showed dramatically
reduced EMT markers, including vimentin expression and levels of SNAIL, ZEB1, and
enhanced epithelial markers such as E-cad expression and PTEN levels compared to the
untreated controls (Fig. 2.9). As a result, the MMP9-inhibited cells lacked expression of EMT
markers in both soft-homogeneous and soft-defect matrix conditions. The RhoA activation
continued to remain low in MMP9-inhibited cells (Fig. 2.9G). Notably, the MMP9-inhibted cells
persisted to express robust EMT signatures on stiff matrices (Fig. 2.9, S8), which shows that the
selected MMP9 inhibitor is not a generic blocker of EMT. In other words, the loss of the ability
of cells to degrade col-IV disabled their sensitivity to the physical defect in the col-IV soft matrix
and the cells only responded to the changes in matrix stiffness.
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Figure 2.9. MMP9 inhibition blocks defect-induced EMT by disabling col-IV
degradation. (A) Representative immunofluorescence images of E-cad, vimentin, and DAPI
in MCF10A cell monolayer after treatment with MMP9 inhibitor on soft, soft-defect, and stiff
PA gels. Scale bar=50m. Average expressions of (B) col-IV, (C) membrane-localized Ecad, (D) vimentin, and average (E) spreading area and (F) aspect ratio of MMP9-inhibted
cells. N>30. *p<0.01 compared to untreated cells on the same substrate (dashed boxes).
Horizontal lines above bars indicate p<0.01 between the indicated substrate conditions. (G)
Fold change from qPCR measurements of SNAIL, ZEB1, RhoA, and PTEN levels relative to
GAPDH control. Gray dashed boxes represent values for wildtype (without drug treatment)
cells. Error bars = SEM. *p<0.01, **p<0.001, and ***p<0.001 compared to soft control
ECMs.
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Figure 2.10. MMP9 inhibition stops col-IV degradation. Representative
immunofluorescence images of col-IV and DAPI on soft control, soft-defect, and stiff PA
gels after 3 days of monolayer culture of MMP9-inhibited cells show high levels of col-IV,
corresponding to the data presented in Fig. 2.9B. Dashed line is used to emphasize edge of
defect. Scale bar=50m.

25

2.4 Defect-induced EMT leads to 3D cellular invasion
through collagen I matrices
An important biological consequence of EMT is the increased cellular invasion into the
surrounding matrix, specifically stromal invasion in cancer cell metastasis.67 To test whether the
defect-induced EMT and cellular mechanoactivation causes these cells to invade in a 3D
environment, we created a multi-layered gel substrate by first synthesizing a type-I collagen (colI) gel on top of soft PA gels, then depositing a layer of col-IV on top of the col-I gel (Fig.
2.11A). It is important to use a soft PA gel as a foundation for this system, otherwise the cells
might sense underlying stiff glass,60,62 which is different from the conditions present in vivo. As
before, we introduced a defect in the col-IV/col-I gel and seeded a cell monolayer on top.
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Figure 2.11. Defect-induced cellular EMT and mechanoactivation cause 3D invasion.
(A) Schematic describing the fabrication of a multi-layered BM-stroma-mimicking scaffold
with soft PA gels, 3D collagen I matrix, and a coating of col-IV. (B) Volumetric
reconstruction of confocal immunofluorescence image z-stacks of actin, vimentin and DAPI
showing the invasion of cells into this layered gel system with an introduced defect. Scale
bar=m. (C) Heatmap showing average number of cells at a given invasion depth, z, and
distance from the defect, d. Quantification of (D) average number of invading cells per unit
area, and (E) average vimentin expression and (F) average actin fibers versus invasion depth,
normalized per unit area containing cells. Error bars = SEM. (G) Representative images
showing the morphology and distribution of invading cell clusters through
immunofluorescence imaging of actin, vimentin, and DAPI at various invasion depths (z) and
distance from the defect (d). Scale bar = 50 m. (H) Volumetric reconstruction confocal zstacks showing negligible invasion of MMP9-inhibted cells around the defect. Scale
bar=m.

After 6 days of culture, we performed confocal microscopy to image for cells within the
3D col-I matrix, which showed extensive invasion of cells underneath the monolayer (Fig.
2.11B). We counted the number of cell nuclei within 5 µm thick confocal z-stacks and
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discretized into 100 µm sections away from the defect. Across at least 7 different samples, we
observed cell invasion over 30 µm deep into the col-I matrix around the defect (averaged within
~200 µm). These invasion depths reduced away from the defect (Fig. 2.11C); yet, we found ~10
µm deep invasion up to 2 mm distance away from the defect (Fig. 2.11B,C). Averaged over the
area at any given distance from the defect, we found that over 2000 cells/mm2 invaded at least 5
µm deep, while ~100 cells/mm2 were able to reach invasion depths of more than 35 µm (Fig.
2.11D).
By imaging for actin and vimentin, we found that the invaded cells showed robust
expressions of actin fibers and vimentin, indicating EMT induction and mechanoactivation,
across varying depths of invasion and distance away from the defect (Figs. 2.11E-G). Cells that
invaded more than 15 µm deep into the 3D col-I matrix showed tube-like formations (Fig.
2.11G; top row, left panels). In comparison, cells closer to the monolayer, i.e., smaller invasion
depth, invaded in the form of larger sheets and clusters (Fig. 2.11G; top row, right panels).
Since earlier experiments in 2D showed that a defect is necessary for EMT stimulation on
soft substrates and MMP9 inhibition disables EMT, we expected a similar outcome in these
multi-layered gels. Indeed, in this 3D gel system, the systems without defects and those with
MMP-inhibited cells showed negligible invasion (Figs. 2.11D,2.12). To verify that the col-I
matrix remains intact around the defect, we stained and imaged for col-I and found robust col-I
expression all around the invading cell population (Fig. 2.13).
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Figure 2.12. Cellular invasion and EMT do not occur without presence of defect.
Volumetric reconstruction of confocal immunofluorescence image z-stacks of actin, vimentin
and DAPI showing lack of invasion of cells on soft, control (no defect) 3D invasion
substrates, corresponding to data shown in Figure 6. Scale bar=m.

Figure 2.13. Collagen-I expression around the invading cells. Representative images of
wildtype/untreated cells (top) and MMP9-inhibited (bottom) invading through the col-I 3D
gels. After 6 days in culture, samples were fixed and stained for DAPI, vimentin, and type-I
collagen. The presence of an intact col-I layer below the seeded monolayer and surrounding
the invading cells indicates that cells are invading into the col-I layer, and not significantly
degrading or sinking the monolayer as a whole. Cells treated with MMP9 inhibitor show no
invasion and the col-I expression remains similar to the wildtype case. Scale bar = 50 m.
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2.5 Discussion and Conclusions
Our findings reveal that physical defects in the BM matrix can initiate disease-like
cellular transformation in the form of EMT and invasion. Thus, the known BM degradation
caused by the pathogenic transformation of cells through acquired EMT signatures might not be
a one way process. Instead, physical composition of the BM matrix plays a more proactive role
in triggering the disease-aiding EMT and motility in normal epithelial cells.
Through mechanotransductive signaling, stress fiber formation and morphological
adaptation,73-75,78,90 cellular EMT and invasion can respond to the stiffness and topography of
their microenvironments,19,75,76,83,90-94 which themselves undergo dramatic mechanical changes in
cancer and fibrosis.35,86,90,95,96 In particular, the basement membrane around tumors in situ
undergoes degradation and becomes heterogeneous as cells exhibit mesenchymal signatures and
tumor invasiveness increases.81,97,98 Here, we have attempted to deconstruct this intricate
coupling between EMT and BM heterogeneities in pathogenesis. We show that a preexisting
defect in a BM-like soft matrix with a col-IV layer causes broad mesenchymal signatures in a
sheet of normal MCF10A cells (Fig. 2.4). Given that edges in the matrix introduced due to
microfabricated confinement19 or micropatterned ligand patches77 are known to induce EMT, we
expected that the loss of cell-cell cohesion near the open boundary created by the defect would
enhance cellular mechanoactivation, which in turn would lead to cell-cell dissociation and EMT.
Although we did find enhanced EMT signatures around the BM matrix defect, surprisingly the
RhoA activation and stress fiber formation remained low after 3 days of culture (Fig. 2.6). We
also found the defect did not create an artificial space that cells could exploit for increased
proliferation (Fig. 2.14). Thus, unlike the earlier cases of topographic confinement or ligand
patterning,19,77 the physical boundary created by the defect was not enough to increase cellular
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mechanoactivation. Instead, the EMT was triggered by the degraded col-IV, which in turn
enhanced cellular mechanoactivation. In retrospect, given that these experiments were conducted
on a soft matrix, it is not surprising that the cells maintain low mechanoactivation and stress fiber
formation regardless of a physical defect until EMT induction.

Figure 2.14. Cell proliferation increases over time, not spatially on soft-defect
substrates. Average cells/mm2 after 1, 3, and 6 days in culture on soft defect substrates.
N>15. Horizontal lines above bars indicate p<0.01 between the indicated substrate
conditions.

In another mode of matrix-regulated EMT, epithelial cells cultured on stiff matrix quickly
undergo cellular mechanoactivation, marked by higher stress fiber formation and morphological
elongation, developing somewhat concurrently with the EMT, as shown earlier 19,73-76,78 and
reproduced here on a collagen IV-laden matrix (Fig. 2.6). In the case of defective BM matrix,
stress fiber formation increases after the EMT induction over 6 days of culture. Thus, since the
BM discontinuities led to cellular EMT even on a soft matrix and without stress fiber formation
in the first 3 days (Figs. 2.4, 2.6), we concluded the main cause of BM defect-induced EMT is
not cellular mechanoactivation. We observed that col-IV expression near the defect was lower
than the control conditions, which indicated that the degraded col-IV fibrils around the defect
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might directly initiate an EMT response. Consistent with this hypothesis, it has been previously
shown that external introduction of col-IV fibrils into the culture media can induce EMT-like
signatures in mammary epithelial cells.99 Indeed, when the col-IV degradation was disabled
through MMP9 inhibition, the EMT signatures around the matrix defect vanished. Notably, since
the EMT on the stiff matrix persists even after MMP9 inhibition, it can be assumed that the used
pharmacological inhibitor is not a universal EMT blocker.
Our results point to the following framework for BM defect-induced EMT – a tear in the
col-IV network allows the cellular MMP9 to access col-IV binding sites and stimulate
degradation; the degraded col-IV fibrils initiate EMT signaling within 3 days; the EMT
induction propagates through the epithelial layer in a spatiotemporal manner; the defect-induced
EMT and ECM stiffness can both independently enhance cellular mechanoactivation; the EMTinduced cellular mechanoactivation could provide a positive feedback for EMT.
In physiological settings, cellular EMT and mechanoactivation leads to cell migration and
invasion through the surrounding tissue environments. We have shown that the EMT-based
cellular transformation due to BM matrix defect triggers wide-ranging changes in the cells,
including activated actin-myosin force machinery. On a defective collagen IV-laden 3D collagen
I matrix, we found that the defect-induced EMT enabled the MCF10A cells to undergo EMT and
invade through the collagen I matrix. Thus, physical defects in a BM-like matrix do not merely
induce transient or benign forms of EMT and mechanoactivation signatures. Instead, these
defect-induced cellular changes have real consequences for in vivo situations of BM degradation
and stromal invasion, as clear from the measured distant 3D cellular invasion within 6 days of
culture (Fig. 2.11). After MMP9 inhibition, both the EMT induction and cellular invasion
completely stopped. In organ level experiments, overexpression of MMPs, through macrophages
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and fibroblasts, has been shown to induce EMT.100-102 In a new advance, we have discovered
that normal epithelial cells can exploit preexisting defects in a soft BM matrix to degrade col-IV
through MMP9 and attain disease-progressing phenotypes of EMT and 3D invasion. It is already
known that MMP9 activity in immune and cancer cells potentiates lung metastasis,103 promotes
tumor vascularization,104 and predicts breast cancer brain metastasis.105 Additionally, upregulated
MMP1 and MMP2 are known to degrade collagen-rich environments,9,106 including the basement
membrane,107 and accelerate tumor invasion. Our findings provide further indication that MMP9
activity in particular may play a broad role in BM matrix degradation, which would further
promote tumor cell invasion and stromal matrix remodeling through MMP1/2 activity.
Given that the BM microenvironment is composed of many proteins, including
laminin,7,8 the future in vitro BM models should go beyond the col-IV coating for improved in
vivo impact of our findings of BM defect-induced cellular response. Rise in ligand density has
been shown to diminish EMT even on stiff substrate through upregulation of integrin 4 and
Rac1 activity.108 Thus, it is possible that additional BM proteins might enhance cell-BM
adhesions and reduce the defect-induced EMT invasion. Since laminin in particular has also
been shown to play a critical role in breast cancer metastasis,108,109 its presence in the BM matrix
might provide better insights into cell invasion around defective BM matrix. With progressively
increasing complexity, the BM-mimicking in vitro models are likely to provide a more accurate
understanding of broad cellular response to mechanical defects and heterogeneities in the BM
matrix.
.
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Chapter 3: Epithelial cells sense distant
stiffness through ECM deformation and
realignment
3.1 Introduction
As cells interact with their extracellular environment, they sense and distinguish many
different properties that influence and control their behavior. The mechanobiology field has
robustly studied and shown how various cell types respond to the mechanical stiffness of their
environment. Mesenchymal stem cells have been shown to alter their differentiation in response
to substrate stiffness, becoming neuronal cells on soft substrates and osteoblasts on stiff. 22
Fibroblasts and epithelial cells have been shown to migrate faster on stiff substrates and their
morphologies reflect these changes as they become more polarized and their spread areas
increase.19,26,54,55,110-113 In 3D, cells respond to more than just stiffness of their physical
extracellular microenvironment. The fibrous architecture of 3D collagen hydrogels has been
shown to guide cell migration through fiber bundling and realignment.114-117 In 3D fibrous
matrices, cells are known to sense and respond to the architecture of the fibers themselves,
including the size of the fibers and the degree of crosslinking, both of which can be tuned in
vitro.118-121 All of these studies have shown how cells can sense the properties of their immediate
matrix, yet, cells natively reside within a complex, layered matrix of variegated stiffnesses.2
Furthermore, pathologies such as cancer dynamically alter matrix mechanics, which further adds
to the complexity of the layered cellular microenvironment.
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In tumorous environments in vivo, the stiffness of the ECM can vary across the scale of
just a few cells. In invasive carcinomas, stiffness maps of mammary ductal tissues have shown
highly heterogeneous stiffness, with changes of nearly 10 kPa over the range of just 5 μm.122
Outside of cancer, ECM stiffness also greatly changes during wound healing and with the onset
of fibrosis.123-125 While we know that the cells that are in direct contact with these highly fibrotic,
stiff environments are drastically affected, it is unknown if and to what extent cells away from
these regions are affected.
It has been shown that cells are able to generate deformations through large distances in
fibrous matrices. Fibroblasts and epithelial cells have been shown to deform and remodel their
surrounding ECM.126-128 In some cases, the effects of in-plane deformations can be seen up to
100 μm away.129 With this in mind, and the heterogeneous nature of the tumor
microenvironment, it is highly possible that the effects of regions of increased stiffness could
stretch well beyond their immediate surroundings, possibly hundreds of microns away. This
could have major implications in disease progression, where an increase in stiffness in one
region could affect cell behavior in a distant region, causing matrix remodeling and stiffening,
thereby extending the effect of the primary region. This further complicates the study and
treatment of epithelial pathologies, such as cancer development and progression.
In breast tissue, cellular abnormalities can develop within the milk duct.130 While they
can start off as non-invasive, benign tumors, as the abnormality grows and restructures its
microenvironment through matrix deposition and alignment, the tumor can quickly become
invasive and malignant.131 As this process occurs, we ask the question: can neighboring, yet
distant, normal ductal cells sense this change and, in turn, become cancerous themselves? Also,
can the cells within a developing ductal tumor, whether it be benign or malignant, sense the
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stiffness of distant tumors, further exacerbating their invasive behaviors and remodeling of their
local environment?
In this study, we present a novel multi-layered matrix scaffold and analyze single cell
migration to tackle these questions. We layer a fibrous collagen gel of varying thickness on top
of a polyacrylamide gel, whose stiffness we can tune, and then culture one normal (MCF10a)
and one cancerous (MDA-MB-231) cell line on top in separate experiments. According to our
measurements, while normal epithelial cells are unable to sense distant stiffness, cancerous
epithelial cells are able to sense and adapt their behavior to distant substrate stiffness up to nearly
20 μm away. They are able to accomplish this through coordinated actin fiber accumulation and
alignment, allowing them to generate an adequate amount of deformation in the intermediate
collagen network to deform and sense the underlying, “distant” PA substrate.

3.2 Materials and Methods
3.2.1 Layered collagen-polyacrylamide gel fabrication
Polyacrylamide gels were made by mixing acrylamide and bis-acrylamide with ultra-pure
water in the following acrylamide:bis-acrylamide (A:B) percentages of 4%:0.2% for 0.5 kPa PA
and 15%:1.2% for 109 kPa PA. Stiffnesses were confirmed using AFM. After removing the air
from the precursor solutions, ammonium persulfate (APS) and N-N’-N-N’-tetramethyl
ethylenediamine (TEMED) were added to the mixture and PA gels were allowed to fully
polymerize for 30 minutes. Gels were washed and stored in Dulbecco’s Phosphate Buffered
Saline (DPBS) (Fisher Scientific) at 4 C until layering of collagen was performed. Before
addition of collagen, PA gels were sterilized using ultraviolet light for at least 30 minutes. After
sterilization, gels were then treated with 0.5 mg/ml Sulfo-SANPAH solution (Thermo Fisher) to
activate the surface of gels to allow for collagen attachment. Rat-tail collagen I (Advanced
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Biomatrix) solution was prepared at a concentration of 1.3 mg/ml and adjusted to a pH ~8 using
sterile NaOH. This collagen solution was then added in specified volumes on top of the activated
PA gels and then allowed to polymerize in an incubator at 37 C and 5% CO2. Collagen thickness
was verified by adding fluorescent beads and measuring thickness using a Zeiss AxioObserver
inverted microscope and quantified in Figure 1B. Cells were seeded immediately following
collagen polymerization. For glutaraldehyde treated gels, after initial polymerization, layered
substrates were incubated with 0.05% glutaraldehyde at 37 C for 30 min. Following treatment,
gels were washed with DPBS and prepared for cell seeding.

3.2.2 Cell culture and tracking
MCF-10A epithelial breast tissue cells were cultured in tissue culture flasks as previously
described 19 with DMEM/F12 (Invitrogen) supplemented with 5% (v/v) horse serum
(Invitrogen), 20 ng/mL epidermal growth factor (EGF, Miltenyi Biotec Inc), 0.5mg/mL
hydrocortisone (Sigma-Aldrich), 100ng/mL cholera toxin (Sigma-Aldrich), 10 ug/mL insulin
(Sigma-Aldrich), and 0.1% (v/v) Normocin antibacterial, antifungal, and antimycoplasma cell
media supplement (Invivogen). MDA-MB-231 epithelial breast adenocarcinoma cells were
cultured with DMEM (Invitrogen) supplemented with 10% (v/v) fetal bovine serum (FBS) and
0.1% (v/v) Normocin. For cell migration studies, cells were seeded on top for 18 hours before
being transferred to a Zeiss AxioObserver (Carl Zeiss Microscopy) inverted microscope with an
incubation chamber kept at 37 C and 5% CO2. For studies involving ROCK inhibition, cells
were allowed to attach for 12 hours, after which culture media was replaced with media
containing 10 μM Y27632 ROCK Inhibitor (EMD millipore). Cells were tracked at least 12
hours following initial seeding time. ImageJ (NIH) and the Manual Tracking plugin (NIH) were
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used to quantify and sort cell tracks. Single cells were selected and tracked for a minimum of 4
hours. Tracks were then imported to MATLAB and analyzed using a custom script.

3.2.3 Immunofluorescence and confocal microscopy
After 2 days in culture, cells were fixed with 4% paraformaldehyde (Electron Microscopy
Sciences). Cell staining was performed by permeabilization of cell membrane with 0.5% TritonX 100 (Sigma-Aldrich) and blocking with 1% bovine albumin serum (BSA) (EMD millipore).
After thoroughly rinsing the substrates with DPBS, cells were stained with 10mg/mL DAPI
(Santa Cruz) and rhodamine phalloidin (Life Technologies) both at ratios of 1:500 (v/v) in
staining buffer (0.5% BSA in DI water) for 30 min at RT. Confocal images were taken using a
Zeiss LSM 880 laser-scanning confocal microscope (Carl Zeiss Microscopy). Images were
analyzed using ImageJ (NIH).

3.2.4 Collagen deformation quantification and analysis
In order to track deformation in and through the collagen gel, 0.2 μm diameter
fluorescent carboxylated polystyrene beads (Thermo-Fisher) were mixed into collagen solution
at a 0.5% (v/v) dilution. 1 μm diameter fluorescent carboxylated polystyrene beads were also
mixed into PA gels prior to polymerization in order to track deformation in PA as well. After cell
seeding, collagen deformation was tracked on the Zeiss AxioObserver epifluorescent
microscope. Deformations throughout the collagen gel were recorded in Z-stacks with 5 μm step
sizes in order to visualize the entire gel. Bead movements were analyzed using the PIV software
plug-in for MATLAB.132,133
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3.2.5 Statistical Analysis
Unless stated otherwise, reported values are the mean + standard error of the mean
(SEM). To identify significant differences between any of the ECM conditions and drug
treatments, ANOVA analysis was performed using Origin. Differences were taken to be
significant for p < 0.01.

3.3 Results
3.3.1 Cancer cells sense distant matrix stiffness through a layer of collagen
matrix, but normal cells do not.
To investigate whether epithelial cells sense distant stiffness, we fabricated a layered
hydrogel system, consisting of a PA gel as the distant matrix and a collagen gel to simulate the
immediate ECM. The PA gels were fabricated at 2 different stiffnesses: 0.5 kPa (soft) and 110
kPa (stiff) (Fig. 3.1C). Collagen was layered on top in three thicknesses: a monolayer “coating”,
a 10 μm “thin” gel, and a 50 μm “thick” gel (Figs. 3.1A,B). These stiffness and thickness
variations lead to 6 different matrix scaffolds, which we will denote as: “soft-coated”, “softthin”, “soft-thick”, “stiff-coated”, “stiff-thin”, and “stiff-thick”. After fabrication, cells were
seeded on top of the layered gels. To understand the ability of epithelial cells to sense distant
stiffness, we tracked cell migration over two days in culture.
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Figure 3.1. Fabrication and quantification of layered hydrogel substrates. (A)
Representative diagram of all six layered hydrogel setups. (B) Quantification of collagen gel
thickness of fabricated hydrogels. Box represents 10-90% of data with bar at mean value.
Error Bars = SD. N>20. (C) Young’s Moduli for all six layered hydrogel setups, as measured
by AFM. Error Bars = SEM. N>30.
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The normal epithelial cells (MCF-10A) migrated faster on stiffer PA gels with a
monolayer coating of collagen. However, when seeded on either thin or thick collagen gels, they
showed insignificant difference in migration speed or persistence (Figs. 3.2A,B) when compared
against varying stiffness of the underlying PA stiffness. Normal cells did show a slight increase
to the persistence of their migration, a measure of the overall displacement of a cell divided by
its total distance traveled. Lower persistence values describe the so called ‘wandering’ cells that
travel large distances while displacing a short distance from their origin, either by retracing their
previous steps, or by seemingly “orbiting” around their origin point. Persistence values closer to
1 indicate cells with more directed migration, where every step they take contributes to
increasing their overall displacement, much like a cancer cell breaking away from the tumor site.
On thin collagen gels with stiff PA, normal cells showed 20% more persistent migration
compared to coated gels, and their persistence continued to increase on thicker collagen gels,
where they showed 30% more persistent migration (Fig. 3.2B). These results show that normal
epithelial cells are unable to sense distant matrix stiffness and only respond to the properties of
their immediate surroundings.
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Figure 3.2. Cancerous epithelial cell migration is sensitive to distant stiffness on
thin collagen platforms. (A) Representative cell migration trajectories for normal
MCF10A and cancerous MDA-MB-231 epithelial cells. All tracks represent a 4 hr
migration period with 30 min intervals. N = 15. Scale bar = 100 μm (B & C) Average
cell migration and migratory persistence of (B) normal and (C) cancerous epithelial
cells. Black horizontal bars represent significant statistical difference between values
of the same collagen thickness, colored horizontal bars represent significant statistical
difference between values of same PA stiffness. All p < 0.01. Error Bars = SEM.
N>20.
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In contrast, breast cancer cells (MDA-MB-231) showed a remarkable ability to
distinguish distant stiffness on thin collagen gels. On both coating and thin collagen, cancer cells
showed much faster migration with stiff PA, with an 80% increase on coating gels and a 40%
increase on thin collagen gels. Interestingly, despite the similar migration speeds, cancer cells
tended to “retrace” their own steps on stiff-coated gels, a behavior similar to cancer cells on soft
gels and normal cells, yet they traveled large total distances (Fig. 3.2A). On stiff-thin substrates,
cells covered large distances and displaced far away from their origin point, resulting in ~40%
more persistent migration compared to stiff-coated substrates (Fig. 3.2C). As mentioned
previously, cancer cells grown on soft-coated substrates had a tendency to retrace their steps, as
seen by their short and compact trajectories (Fig. 3.2A). In contrast, cells on soft-thin and softthick substrates showed much more directed migration with 30% and 20% more persistent
migration, respectively, compared to coated gels (Figs. 3.2A,C). On thick collagen gels, cancer
cells were unable to sense distant stiffness, showing similar migration trajectories and equally
persistent migration (Figs. 3.2A,C). The migration speeds on soft-thick versus stiff-thick
matrices did not significantly differ, and were around the same magnitude as cells on soft-coated
or soft-thin substrates (Fig. 3.2B). These findings indicate that a cancer cell’s migration speed
and trajectory is sensitive to both distant stiffness and its immediate surroundings, contrasting the
response of normal epithelial cells.
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3.3.2 Cancer cells exhibit elongated shapes and rise in stress fibers in response
to distant layers of stiff matrix.
To further investigate the mechanism behind the cells’ ability, or inability, to sense
distant stiffness, we also analyzed the whole-body morphology and the intra-cellular actin
structure of the cells on varying matrices. Both normal and cancer cells became more elongated
on collagen gels thicker than a coating (Figs. 3.3A,B). Normal cells showed a significant
increase in cell aspect ratio on thin or thick collagen gels, becoming ~50% more elongated,
however they still remained much less elongated than cancer cells on the same substrates (Fig.
3.3B). Following this trend, normal cell roundness decreased on finite thickness collagen gels,
showing ~50% reduction from soft-coated substrates and ~30% reduction compared to stiffcoated substrates (Fig. 3.3D). These changes to cell shape occurred with very little change to
overall cell area, and normal cell areas were much smaller than those of cancer cells in general.
Similar to their migration behavior, cancer cells showed greater sensitivity to distant
stiffness with their morphology. Cancer cells were nearly twice as elongated on thin and thick
collagen substrates compared to coated substrates (Figs. 3.3A,B). Despite their high migration
speeds, cancer cells were less elongated on stiff-coated substrates. Their area was also 50%
larger than that of cells on any other substrate, and their roundness was twice that of cells on thin
and thick collagen with stiff underlying PA (Figs. 3.3A-D).
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Figure 3.3. Cancerous epithelial cell morphology and actin cytoskeleton reflect
distance sensitivity observed during cell migration. (A) Representative cell
morphologies (top) and actin images (bottom) for normal MCF10A and cancerous
MDA-MB-231 epithelial cells. N = 15 for representative morphologies. Scale bar = 50
μm (B-E) Average (B) cell aspect ratio, (C) roundness, (D), spread area and (E) Factin expression of normal and cancerous epithelial cells. Black horizontal bars
represent significant statistical difference between values of the same collagen
thickness, colored horizontal bars represent significant statistical difference between
values of same PA stiffness. All p < 0.01. Error Bars = SEM. N>20.
This behavior on gels with collagen coating can be explained due to a lack of fibrous collagen
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network to allow cells to optimally stretch and deform, thereby reducing their aspect ratio and
increasing their roundness. Another notable phenomenon is that cancer cells on thin collagen
gels with soft underlying PA were nearly three times rounder than cells on thick collagen or stiff
underlying PA (Fig. 3.3D). Interestingly, these cells were still highly elongated. These cells
appear to utilize the collagen architecture, resulting in high aspect ratio due to development of
stable cell protrusions, to sense the distant soft PA, resulting in more rounded cell morphologies,
similar to cells in immediate contact with soft PA (Figs. 3.2A,C).
Changes to cell morphology generally arise from modification to the internal
cytoskeleton. To examine these intracellular changes, we stained and observed the actin fibers
using phalloidin. The actin structure of normal cells did not significantly vary across any of the
matrix conditions (Fig. 3.3E). By contrast, cancer cells showed large variations in actin structure,
including a large increase in actin fiber accumulation on thin collagen substrates with stiff
underlying PA. On both coating and thin collagen matrices, cancer cells showed ~3x the actin
fiber accumulation with stiff underlying PA when compared to the soft PA layer. However, this
difference in stiffness-sensitive actin structure disappeared on thick collagen gels. Cells on stiffthin substrates also showed over twice as much actin fiber accumulation compared to cells on
stiff-coated substrates. In case of a soft underlying PA layer, the actin fiber accumulation in
cancer cells increased only when they sat atop a thick collagen gel.

3.3.3 Cancer cells sense distant matrix stiffness by deforming the intermediate
collagen layer.
From the migration and morphology assays, cancer cells appear to be able to deform and
align the surrounding collagen network to deform and sense the underlying PA gel. In order to
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confirm this possibility and further investigate the extent of the depth sensing, we mixed beads
into the collagen gel to track and measure the matrix deformation. In order to measure the
deformation caused by cells, we first trypsinized the cells and then imaged bead positions over
time to track their movements throughout the collagen layer. We then used the PIV lab tool in
MATLAB to analyze the bead movements. In thin collagen gels, cancer cells were able to induce
deformation throughout the entire collagen layer (Fig. 3.4A). Bead displacements within the
collagen were most erratic on soft, thin gels, while bead movements in stiff-thin substrates and
both soft-thick and stiff-thick platforms were fairly orderly (Fig. 3.4A). Notably, the magnitude
of deformation was ~30 % higher on stiff-thin gels. We also measured small deformations within
the top layer of the PA gel itself. On thin collagen gels, cell-generated deformations were able to
reach the underlying PA, resulting in minor bead movements in the PA layer (Figs. 3.4A, B). On
thick collagen, cells generated forces up to ~20 μm into the collagen. Since the matrix
deformation did not transmit through the entire collagen layer, there was no deformation
observed in the underlying PA layer (Fig. 3.4B).
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Figure 3.4. Cancerous epithelial cells sense distant PA stiffness through coordinated
deformation of immediate collagen. (A, left) Representative images of cells and beads
within collagen layer prior to (left) and after (right) release of cells. Scale bar = 25 μm (A,
right) Representative bead displacement diagrams through the thickness of the collagen layer
and at the collagen-PA interface. (B) Average bead displacement within collagen layer after
release of the cell. Black horizontal bars represent significant statistical difference between
values of the same collagen thickness. p < 0.01. Error Bars = SEM. N>5.
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3.3.4 Loss of force generation disables depth-sensing in cancer cells.
To create the deformations seen in the collagen layer, cancer cells are likely to utilize
both the fibrous and viscoelastic nature of the collagen matrix, as well as coordinated actinmyosin contractile networks. To confirm this behavior, we sought to restrict these two
phenomena to understand their contribution to depth sensing. To eliminate coordinated cell
contractile forces, we treated cells with Y27362 ROCK inhibitor, which inhibits the activation of
ROCK by preventing the binding of RhoA, which activates ROCK 1/2 and promotes myosin
contractility. When treated with ROCK inhibitor, cells had a tendency to produce uncoordinated
protrusions (Fig. 3.5A). However, these protrusions did not lead to an increase in migration
speed. On both thin and thick collagen gels, as well as soft and stiff PA, cell speed slowed
compared to control cases (Fig. 3.5B). Cell migration was also far less persistent, resembling
control cells on soft substrates (Fig. 3.5C). Despite their propensity to generate an increased
number of protrusions, cells maintained mostly round bodies with very thin and random
protrusions (Fig. 3.5A). This resulted in reductions in overall cell aspect ratio and total spread
area, as well as an increase in cell roundness, compared to controls (Figs. 3.5A,D-F).
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Figure 3.5. Loss of actin-myosin contractility inhibits cancer cell sensitivity to
distant stiffness. (A) Representative actin images for MDA-MB-231 breast cancer
cells after treatment with Y27362 ROCK inhibitor, with plots of average (B) migration
speed, (C) cell aspect ratio, (D), migratory persistence, (E) spread area, and (F)
roundness. Scale bar = 50 μm. Grey dashed boxes represent values for untreated cells.
Error Bars = SEM. N>20.
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3.3.5 Crosslinking of the collagen layer disables cellular response to distant
stiff matrix.
To externally disable the ability of cancer cells to deform the intermediate collagen layer
without altering the intracellular machinery, we fabricated the layered gel setups and then treated
the collagen with glutaraldehyde, a reagent that increases collagen crosslinking. By crosslinking
the collagen prior to cell seeding, we reduce the viscous properties of the collagen substrate,
creating a more linear elastic material, similar to the distant PA. This crosslinking is expected to
restrict the cell’s ability to deform the matrix. In contrast to cells treated with ROCK inhibitor,
the untreated cells on layered substrates with cross-linked collagen showed increased migration
speeds, similar to those on control stiff-thin substrates (Fig. 3.6B). Notably, the migration
patterns of these cells showed very little persistence, similar to cells migrating on coated
substrates (Fig. 3.6C). Similar to inhibition of ROCK, crosslinking of the collagen layer resulted
in less elongated cells that were typically much smaller than cells on control collagen layers
(Figs. 3.6D-F).
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Figure 3.6. Crosslinking of fibrous collagen matrices inhibits cancer cell sensitivity
to distant stiffness. (A) Representative actin images of MDA-MB-231 cells on layered
substrates with thin or thick collagen layers, in which collagen was crosslinked by
treatment with 0.05% glutaraldehyde. Scale bar = 50 μm. For the four matrix conditions
of soft-thin, soft-thick, stiff-thin and stiff-thick, average (B) migration speed, (C) cell
aspect ratio, (D), migratory persistence, (E) spread area, and (F) roundness of cancerous
epithelial cells cultured. Grey dashed boxes represent values for control (un-crosslinked)
substrates. Error Bars = SEM. N>20. (G) Young’s Moduli for layered hydrogel setups
treated with 0.05% glutaraldehyde, as measured by AFM. Grey dashed boxes represent
values for untreated substrates. Error Bars = SEM. N>20.
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3.4 Discussion and Conclusions
We have shown that while normal epithelial cells show very little ability to sense distant
stiffness, cancer cells were able to deform their immediate ECM to sense distant matrix
properties. When cancer cells were cultured on thin collagen layers, their migration speed was
much faster with stiff underlying PA. Cells cultured on finitely thick collagen layers also showed
more persistent migration. When cultured on thick collagen gels, this stiffness-dependent
difference diminished, and cells behaved the same with both soft and stiff underlying PA. As
collagen thickness increased, cell aspect ratio followed suit, whereas cell area and cell roundness
decreased. Interestingly, cancer cells on soft-thin substrates showed decreased cell aspect ratio
and high cell roundness, behaving as though they were in direct contact of the underlying PA
gels. Cancer cells were able to sense distant matrix stiffness through two mechanisms: adequate
force generation through actin fiber assembly and myosin contractility, as well as the ability to
deform their surrounding fibrous collagen matrix.
While this study is limited to only exploring the extent of distance sensing in 2D,
observing how well these cells sense distant matrix properties in 3D is an important next step.
Also, since we have found that the fibrous collagen network is crucial to a cell’s ability to sense
distant stiffness, we can next tune the properties of the fibers themselves, such as fiber size, to
see what influence they have on distant stiffness sensing. We also do not control for matrix
degradation or collagen bundling in this study, which could possibly be a critical mechanism
utilized by cells to deform their immediate surrounding ECM to sense distant matrix properties.
Importantly, we found that the extent to which cancerous epithelial cells can sense distant
matrix stiffness is in the range of 20 μm, much less than that seen from fibroblast cells, but much
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greater than previously reported. There is a possibility that even normal epithelial cells could
sense distant matrix properties to a greater extent than previously reported, although that limit is
not explored here. This could implicate that the presence of a soft or stiff heterogeneity in the
ECM, such as a tumor, could have an effect on more than just the cells in its immediate contact.
This also could indicate that distant cells surrounding the tumor could also have an effect on the
malignancy of that tumor.
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